MannKind Corporation - MNKD - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 26, 2013

MannKind Corporation - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
MNKD	Nasdaq	2834	http://www.mannkindcorp.com/	6.55 -0.30
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for MannKind Corporation 3 Stocks Near 52-Week Highs Worth Selling - May 24th, 2013 6:00 pm Most active Nasdaq-traded stocks - May 24th, 2013 4:04 pm 3 Humongous Health Care Stocks This Week - May 24th, 2013 2:18 pm MannKind Stock Falls On Unusually High Volume (MNKD) - May 24th, 2013 1:00 pm MannKind shares leap as web site says firm is a ripe takeover target - May 24th, 2013 9:54 am Biotech Stock Mailbag: Amarin, MannKind, Palatin - May 24th, 2013 5:00 am MannKind's Run to Glory - May 23rd, 2013 1:41 pm [video] Options Activity Ahead of Pandora Earnings - May 23rd, 2013 1:26 pm Commit To Buy MannKind Corp At $2.50, Earn 28% - May 23rd, 2013 12:16 pm Arena Buyout More 'Highly Probable' Than MannKind - May 23rd, 2013 11:20 am [video] Nasdaq Check: Tech Stocks Recover - May 23rd, 2013 11:02 am What's behind put surge in MannKind - May 23rd, 2013 10:39 am The Coming Diabetes Wars - May 23rd, 2013 9:48 am Largest option buying in equities so far - May 23rd, 2013 9:44 am 2 Biotechs to Avoid, 1 to Buy - May 23rd, 2013 9:06 am MannKind's Afrezza And The Oramed Threat - May 23rd, 2013 6:10 am American Capital Adds to Global Investment Team and 2 More Heavily Traded Stocks to Follow - May 22nd, 2013 3:31 pm MannKind attracts huge call strategy - May 22nd, 2013 10:04 am Largest option buying in equities so far - May 22nd, 2013 9:27 am Pricing A Highly Probable Takeover Of MannKind - May 22nd, 2013 3:28 am View All Current Headlines >>